Tianda Pharmaceuticals Limited (stock code: 00455) reports that its authorized share capital remained at 4,000,000,000 ordinary shares at a par value of HKD 0.1 each, totaling HKD 400,000,000 as of 30 November 2025. The number of issued shares stood at 2,150,041,884, with no changes from the previous month.

According to the submission, no new shares were issued or repurchased during November. Under the existing share option scheme, 215,004,188 shares remain issuable, and no options were exercised during the period.